EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer

Gökhan Uçar, Serhat Sekmek, İrfan Karahan, Yakup Ergün, Özlem Aydın İsak, Sezai Tunç, Mutlu Doğan, Fatih Gürler, Doğan Bayram, Yusuf Açıkgöz, Selin Aktürk Esen, Burak Civelek und 9 weitere

Oncology · 2024

DOI: 10.1159/000540517 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Oncology, 2024. Verfasst von Gökhan Uçar und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Locoregional gastric cancer is a still serious problem and perioperative treatments may improve the success of management. Different regimens were examined. The present study purposed to compare the efficacy of fluorouracil-leucovorin-oxaliplatin-docetaxel (FLOT) and docetaxel-cisplatin-fluorouracil (DCF) regimens.

Methods

A retrospective multicenter study assessed the patients with locoregional gastric cancer. There are 240 patients (137 DCF, 103 FLOT). Survival rates were compared.

Results

Demographic features were similar between the two groups, but the time period was different. The FLOT group had 7.8% pathological complete response, while the DCF group did not. Disease-free survival was longer in the FLOT than in the DCF group (median not reached – 13.94 months, respectively). Median overall survival was similar (30.9 vs. 37.8 months), but median follow-up affected the analysis. Survival for 36 months was 63% for the FLOT group and 40% for the DCF group (log-rank; p = 0.015).

Conclusion

FLOT regimen was superior to DCF regimen for response and survival rates. DCF is a historical approach. Long-term follow-up period is needed for FLOT treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleDocetaxelMiddle AgedRetrospective StudiesFluorouracilLeucovorinAgedOxaliplatinCisplatinTaxoidsOrganoplatinum CompoundsAdultDisease-Free SurvivalSurvival RateTreatment Outcome

Stichwörter der Autor:innen

DCFFLOTGastric cancerPerioperative treatment

Substanzen

DocetaxelFluorouracilLeucovorinOxaliplatinCisplatinTaxoidsOrganoplatinum Compounds

Autor:innen und Institutionen

  • Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey.
  • Department of Medical Oncology, Antalya City Hospital, Ankara, Turkey.
  • Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey.
  • Department of Medicak Oncology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.
  • Department of Medical Oncology, Ankara Dr. AY Oncology Training and Research Hospital, Ankara, Turkey.
  • Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey.

Zitieren

APA

Uçar, G., Sekmek, S., Karahan, İ., Ergün, Y., İsak, Ö. A., Tunç, S., Doğan, M., Gürler, F., Bayram, D., Açıkgöz, Y., Esen, S. A., Civelek, B., Köş, F. T., Bal, Ö., Algın, E., Eren, T., İmamoğlu, G. İ., Urakçı, Z., Yazıcı, O., …, & Uncu, D. (2024). The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer. Oncology. https://doi.org/10.1159/000540517

Vancouver

Uçar G, Sekmek S, Karahan İ, Ergün Y, İsak ÖA, Tunç S, et al. The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer. Oncology. 2024. doi:10.1159/000540517

BibTeX
@article{Uar2024,
  author = {Uçar, Gökhan and Sekmek, Serhat and Karahan, İrfan and Ergün, Yakup and İsak, Özlem Aydın and Tunç, Sezai and Doğan, Mutlu and Gürler, Fatih and Bayram, Doğan and Açıkgöz, Yusuf and Esen, Selin Aktürk and Civelek, Burak and Köş, Fahriye Tuğba and Bal, Öznur and Algın, Efnan and Eren, Tülay and İmamoğlu, Gökşen İnanç and Urakçı, Zuhat and Yazıcı, Ozan and Özdemir, Nuriye and Uncu, Doğan},
  title = {The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer},
  journal = {Oncology},
  year = {2024},
  doi = {10.1159/000540517}
}
Kostenlos starten →